The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States
Open accessAbstract
OBJECTIVES: Obesity is a known risk factor for type 2 diabetes (T2D). We conducted a case-control study to assess the association between body mass index (BMI) and the risk of being diagnosed with T2D in the United States. METHODS: We selected adults (≥ 18 years old) who were diagnosed with T2D (defined by ICD-9-CM diagnosis codes or use of anti-diabetic medications) between January 2004 and October 2011 ("cases") from an electronic health records database provided by an integrated health system in the Middle Atlantic region. Twice as many individuals enrolled in the health system without a T2D diagnosis during the study period ("controls") were selected based on age, sex, history of cardiac comorbidities or hyperinflammatory state (defined by C-reactive protein and erythrocyte sedimentation rate), and use of psychiatric or beta blocker medications. BMI was measured during one year prior to the first observed T2D diagnosis (for cases) or a randomly assigned date (for controls); individuals with no BMI measure or BMI < 18.5 kg/m2 were excluded. We assessed the impact of increased BMI (overweight: 25-29.9 kg/m2; Obesity Class I: 30-34.9 kg/m2; Obesity Class II: 35-39.9 kg/m2; Obesity Class III: ≥40 kg/m2), relative to normal BMI (18.5-24.9 kg/m2), on a T2D diagnosis using odds ratios (OR) and relative risks (RR) estimated from multiple logistic regression results. RESULTS: We included 12,179 cases (mean age: 55, 43% male) and 25,177 controls (mean age: 56, 45% male). We found a positive association between BMI and the risk of a T2D diagnosis. The strength of this association increased with BMI category (RR [95% confidence interval]: overweight, 1.5 [1.4-1.6]; Obesity Class I, 2.5 [2.3-2.6]; Obesity Class II, 3.6 [3.4-3.8]; Obesity Class III, 5.1 [4.7-5.5]). CONCLUSIONS: BMI is strongly and independently associated with the risk of being diagnosed with T2D. The incremental association of BMI category on the risk of T2D is stronger for people with a higher BMI relative to people with a lower BMI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The incidence of T2D was 58% lower (95% CI: 48–66%) among subjects who were assigned to the lifestyle-modification program (with a goal of at least a 7% weight loss of the baseline body weight) than those in the placebo group [33].”
BackgroundPrevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Diabetes Prevention Program Research Group (2009) · The Lancet · doi:10.1016/s0140-6736(09)61457-4 · Cited by 3,020 · cited 1×
“Weight loss was also associated with longterm benefit in a follow-up study of the DPP program, which found that the 10-year cumulative incidence of T2D among participants in the lifestyle-modification program was lower compared with those treated with metformin or in the placebo group [35].”
ResultType 2 Diabetes Mellitus: A Review of Current Trends
Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012) · Oman Medical Journal · doi:10.5001/omj.2012.68 · Cited by 1,338
Carey, V. J., Walters, E. E., Colditz, G. A., Solomon, C. G., Willet, W. C., Rosner, B. A., Speizer, F. E., & Manson, J. E. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009158 · Cited by 827
Ethnicity, Obesity, and Risk of Type 2 Diabetes in Women
Shai, I., Jiang, R., Manson, J. E., Stampfer, M. J., Willett, W. C., Colditz, G. A., & Hu, F. B. (2006) · Diabetes Care · doi:10.2337/dc06-0057 · Cited by 479
Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program
Perreault, L., Kahn, S. E., Christophi, C. A., Knowler, W. C., Hamman, R. F., & the Diabetes Prevention Program Research Group (2009) · Diabetes Care · doi:10.2337/dc09-0523 · Cited by 209
Cited by
Morrison, J., Knoblauch, N., Marcus, J. H., Stephens, M., & He, X. (2020) · Nature Genetics · doi:10.1038/s41588-020-0631-4 · Cited by 591
Blood metabolome predicts gut microbiome α-diversity in humans
Wilmanski, T., Rappaport, N., Earls, J. C., Magis, A. T., Manor, O., Lovejoy, J., Omenn, G. S., Hood, L., Gibbons, S. M., & Price, N. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0233-9 · Cited by 328
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Rachdaoui, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051770 · Cited by 265
Teufel, F., Seiglie, J. A., Geldsetzer, P., Theilmann, M., Marcus, M. E., Ebert, C., Arboleda, W. A. L., Agoudavi, K., Andall-Brereton, G., Aryal, K. K., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00844-8 · Cited by 159
Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men
Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2016) · Diabetologia · doi:10.1007/s00125-015-3846-7 · Cited by 65
Metadata
- Authors
- Ganz, M. L., Wintfeld, N., Li, Q., Alas, V., Langer, J., & Hammer, M.
- Venue
- Diabetology & Metabolic Syndrome
- Published
- 2014-04-03
- Volume
- 6
- Issue
- 1
- Pages
- 50-50
- ISSN
- 1758-5996 (ISSN-L)
- OpenAlex
- W2108904801
- Cited by
- 242
- References
- 9
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. https://app.cochat.ai/papers/10.1186/1758-5996-6-50
- The paper
- Ganz, M. L., Wintfeld, N., Li, Q., Alas, V., Langer, J., & Hammer, M. (2014). The association of body mass index with the risk of type 2 diabetes: a case–control study nested in an electronic health records system in the United States. Diabetology & Metabolic Syndrome. https://doi.org/10.1186/1758-5996-6-50
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.